Chemorepellent signaling through the PACAP/lysozyme receptor is mediated through cAMP and PKC in Tetrahymena thermophila

Pituitary adenylate cyclase-activating peptide and lysozyme are potent chemorepellents which act through the same receptor in Tetrahymena. Using in vivo behavioral studies, we have found that the pituitary adenylate cyclase-activating peptide/lysozyme receptor appears to signal through a G-protein pathway which is mediated through both adenosine 3'5'monophosphate and protein kinase C. Avoidance to pituitary adenylate cyclase-activating peptide and lysozyme is inhibited by the G-protein inhibitor, guanosine 5'-O-(2thiodiphosphate), the adenosine 3'5'monophate analog, Rp-adenosine-3', 5' cyclic monophosphorothioate, and the protein kinase C inhibitors, calphostin C and bisindolylmaleimide IV. A proposed model for signaling through the pituitary adenylate cyclase-activating peptide/lysozyme receptor is briefly outlined.     

Chemosensory responses of Tetrahymena thermophila to CB2, a 24-amino-acid fragment of lysozyme

While lysozyme is a depolarizing chemorepellent in Tetrahymena, the entire lysozyme molecule is not necessary to activate the lysozyme receptor. Reduced lysozyme was cut into three fragments by cyanogen bromide cleavage and the fragments (CB₁, CB₂ and CB₃) were separated by HPLC. Behavioral bioassays showed that the carboxy-terminal 24-amino-acid fragment, which we call CB₂, is 100 times more active than intact lysozyme as a chemorepellent. CB₂ appears to activate the same receptor as lysozyme because behavioral cross-adaptation is seen between these two compounds and an antibody generated to the purified lysozyme receptor blocks responses to both lysozyme and CB₂. This is further supported by the observation that neomycin, which is a competitive inhibitor of lysozyme binding, also inhibits CB₂ responses. This inhibition may be due to the fact that neomycin is highly positively charged (+5 at pH 7.0) and CB₂ has a net charge of +4 at pH 7.0. Intracellular electrophysiological recordings documented that CB₂ elicits a transient, depolarizing receptor potential that is similar to the lysozyme-induced depolarizations except they are much smaller. CB₂ is a more potent and specific ligand for use in studies of the lysozyme receptor of Tetrahymena. Accepted: 21 February 1999     

Trigeminal chemosensitivity: Differences in relation to the time of the day

Day-night differences of trigeminal chemosensitivity were investigated in 18 healthy volunteers employing both pain-related cortical potentials and pain ratings in response to stimulation of the nasal mucosa with CO2. Day-night differences were found with N 1 P2 amplitudes, P2 latencies and pain ratings. It is concluded that the time of the day must not be ignored when human chemosensitivity is investigated at suprathreshold levels.      

Change in acetylcholinesterase during early phase of experimental spinal cord trauma in primates

Specific activity of acetylcholinesterase has been shown to be decreased following experimental spinal cord trauma (200 gcm) in primates. The decrease in activity was evident at 8, 24, 48 hr and 1 week after injury to the traumatized segments of spinal cord.     

Assessment of immunological parameters during tumour development in a murine model

Natural Killer activity assessed by 51Cr release assay from K-562 cells showed detectable activity from 5th day after tumour transplantation, reaching a peak on 12th day and thereafter showing a gradual decline in the activity. Antibody dependent cell mediated cytotoxicity estimated by 51Cr labelled sheep red blood cells anti SRBC system demonstrated a peak activity on 5th day. Cytotoxic T lymphocyte activity detected by 51Cr release of Dalton's lymphoma ascites target cells showed a peak on 10th day. Antibody complement mediated cytotoxicity revealed a similar pattern as natural killer cell activity.